本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Anchiano Therapeutics Ltd.

4.71
0.0000
成交量:- -
成交額:- -
市值:54.61萬
市盈率:-0.19
高:4.71
開:4.71
低:4.71
收:4.71
52周最高:168.80
52周最低:4.71
股本:11.59萬
流通股本:4.83萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-25.0336
每股收益(LYR):-25.0336
淨資產收益率:-125.60%
總資產收益率:-52.84%
市淨率:0.15
市盈率(LYR):-0.19

資料載入中...

2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/15

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/14

重要事件披露

8-K/A [Amend] - Current report
2021/04/05

重要事件披露

8-K - Current report
2021/03/26

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/26

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/19

重要事件披露

8-K/A [Amend] - Current report
2021/03/17

重要事件披露

8-K - Current report
2021/03/10

企業合併公告

425 - Prospectuses and communications, business combinations
2021/03/10

重要事件披露

8-K - Current report
2021/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/09

企業合併公告

425 - Prospectuses and communications, business combinations
2021/02/08

重要事件披露

8-K - Current report
2021/02/08

企業合併公告

425 - Prospectuses and communications, business combinations
2021/02/02

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/11

企業合併公告

425 - Prospectuses and communications, business combinations
2021/01/05

企業合併公告

425 - Prospectuses and communications, business combinations
2020/12/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/18

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/12/15

重要事件披露

8-K - Current report